<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">349504</id>
  <title nil="true"/>
  <common-name>N-[1-[(6-fluoronaphthalen-2-yl)methyl]pyrrolidin-3-yl]-2-[1-(3-methyl-1-oxidopyridin-1-ium-2-carbonyl)piperidin-4-ylidene]acetamide</common-name>
  <description>N-[1-[(6-fluoronaphthalen-2-yl)methyl]pyrrolidin-3-yl]-2-[1-(3-methyl-1-oxidopyridin-1-ium-2-carbonyl)piperidin-4-ylidene]acetamide is a chemical compound with the formula C29H31FN4O3. With an average molecular weight of 502.60 g/mol, N-[1-[(6-fluoronaphthalen-2-yl)methyl]pyrrolidin-3-yl]-2-[1-(3-methyl-1-oxidopyridin-1-ium-2-carbonyl)piperidin-4-ylidene]acetamide is a heavy molecule.</description>
  <cas nil="true"/>
  <pubchem-id>56603737</pubchem-id>
  <chemical-formula>C29H31FN4O3</chemical-formula>
  <weight>502.6</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T14:07:20Z</created-at>
  <updated-at type="dateTime">2026-08-31T14:07:20Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CC1=C([N+](=CC=C1)[O-])C(=O)N2CCC(=CC(=O)NC3CCN(C3)CC4=CC5=C(C=C4)C=C(C=C5)F)CC2</moldb-smiles>
  <moldb-formula>C29H31FN4O3</moldb-formula>
  <moldb-inchi>InChI=1S/C29H31FN4O3/c1-20-3-2-11-34(37)28(20)29(36)33-13-8-21(9-14-33)16-27(35)31-26-10-12-32(19-26)18-22-4-5-24-17-25(30)7-6-23(24)15-22/h2-7,11,15-17,26H,8-10,12-14,18-19H2,1H3,(H,31,35)</moldb-inchi>
  <moldb-inchikey>AINQBHMFEKHERT-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">502.238019</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>2.8</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM345397</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>N-[1-[(6-fluoronaphthalen-2-yl)methyl]pyrrolidin-3-yl]-2-[1-(3-methyl-1-oxidopyridin-1-ium-2-carbonyl)piperidin-4-ylidene]acetamide</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Benzenoids</superklass>
  <klass>Naphthalenes</klass>
  <subklass nil="true"/>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0299828</sync-id>
  <structure-inchikey>AINQBHMFEKHERT-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>800000000000000000000000000000100020000000000000000000004204200000000000000010000000000040000001000000000000000000000400000000200000000000000020000000000210001000001080000100000000010000040000000000100000000000020106000000000000001000100000400040000000800000000000004080008004000004800000000000040000000000002004000000000000081100002000010000000000088100008000000000000000080000000000000020000000020002000000002000200220041000010000000000010001000040000000000400800000000000000001004080000000</structure-fingerprint>
  <structure-pattern-fingerprint>7034c2008512865081001b68c138a2001a80540081052040003d2062c224c84c7e060050138000000100490a02c000000460022dc08d36610166643900a04010c7110c011290140040921140137a02000805859057211f3748051562442248040c38052f10480220600c0400dd94024c248680700509c14431182c6002510212124008184ef0820808061250482c0008393d181244409e8a5003082060c0448410d310130090c8200a044960057c35104ac04402a943084818814a384cc00a12a01000a404982b3301848684565142980c050010034058200d6102842801830090104d120881010411480411d91320821050043086c2042e1100908852800206</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAlAAAAKQAAAIABBgBgAAAAAQMGQCgAAAAD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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:47:36Z</structure-indexed-at>
</compound>
